Joint Corp
NASDAQ:JYNT
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.62
17.66
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Joint Corp
Joint Corp
Cash & Cash Equivalents
Joint Corp
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Joint Corp
NASDAQ:JYNT
|
Cash & Cash Equivalents
$20.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
22%
|
CAGR 10-Years
24%
|
|
|
Universal Health Services Inc
NYSE:UHS
|
Cash & Cash Equivalents
$106.1m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
|
Encompass Health Corp
NYSE:EHC
|
Cash & Cash Equivalents
$147.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-6%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
Cash & Cash Equivalents
$4.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
67%
|
CAGR 10-Years
35%
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
Cash & Cash Equivalents
$2.9B
|
CAGR 3-Years
41%
|
CAGR 5-Years
39%
|
CAGR 10-Years
19%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Cash & Cash Equivalents
$532.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
64%
|
CAGR 10-Years
30%
|
|
Joint Corp
Glance View
The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. The company is headquartered in Scottsdale, Arizona and currently employs 316 full-time employees. The company went IPO on 2014-11-11. Its segments include Corporate Clinics and Franchise Operations. Corporate Clinics segment is comprised of the operating activities of the Company-owned or managed clinics. The firm operates or manages approximately 96 clinics under this segment. Franchise Operations segment is comprised of the operating activities of the franchise business unit. The franchise system consists of approximately 610 clinics in operation. The company offers a range of membership and wellness packages. The company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
See Also
What is Joint Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
20.7m
USD
Based on the financial report for Sep 30, 2024, Joint Corp's Cash & Cash Equivalents amounts to 20.7m USD.
What is Joint Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
24%
Over the last year, the Cash & Cash Equivalents growth was 29%. The average annual Cash & Cash Equivalents growth rates for Joint Corp have been 2% over the past three years , 22% over the past five years , and 24% over the past ten years .
You don't have any saved screeners yet
